Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Fundrise VCX Stock (VCX) Opinions on Citron Research Short Report Fallout

None

Explosive Market Debut: Social media ignited with excitement over Fundrise VCX's listing, a closed-end fund offering exposure to private giants like OpenAI, SpaceX, Anthropic, and Databricks. Shares skyrocketed nearly 1,900% above the net asset value of about $19 per share within days, underscoring retail investors' frenzy for pre-IPO access.

Short Report Shockwave: The rally abruptly reversed following a high-profile short seller's scathing report, which spotlighted the fund's astronomical premium and past regulatory issues with its sponsor. Trading halts punctuated the plunge from peaks exceeding $500, as skeptics warned of overvaluation.

Persistent Premium Scrutiny: At recent levels around $100-110, conversations persist on the enduring 5-6 times premium to NAV. Optimism lingers on potential liquidity events for holdings like SpaceX, though many urge caution against chasing synthetic exposure at such multiples.

Note: This discussion summary was generated from an AI condensation of post data.

EARLY ACCESS
Receive VCX Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles